Retraction notice to "Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance" [Biomedicine & Pharmacotherapy 153 (2022) 113305] - 21/05/26
Doi : 10.1016/j.biopha.2026.119424
Md. Mominur Rahman a, Md. Rezaul Islam a, Shopnil Akash a, Md. Harun-Or-Rashid a, Tanmay Kumar Ray a, Md. Saidur Rahaman a, Mahfuzul Islam a, Fazilatunnesa Anika a, Md. Kawser Hosain a, Farjana Islam Aovi a, Hassan A. Hemeg b, Abdur Rauf c, ⁎, Polrat Wilairatana d, ⁎
a Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, 1207 Dhaka, Bangladesh
b Department of Medical Laboratory Technology, College of Applied Medical Sciences, Taibah University, P.O. Box 344, Al-Madinah Al-Monawra 41411, Saudi Arabia
c Department of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa, Pakistan
d Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119424- juin 2026 Retour au numéro
Article précédent
- Retraction notice to "Jiedu Tongluo Baoshen formula enhances renal tubular epithelial cell autophagy to prevent renal fibrosis by activating SIRT1/LKB1/AMPK pathway" [Biomedicine & Pharmacotherapy 160 (2023) 114340]
- Di Jin, Yunyun Zhao, Yuting Sun, Jiaojiao Xue, Xiangyan Li, Xiuge Wang
- Retraction notice to "Searching for novel antimicrobial agents among hydrazide-hydrazones of 4-iodosalicylic acid" [Biomedicine & Pharmacotherapy 153 (2022) 113302]
- Łukasz Popiołek, Katarzyna Tuszyńska, Anna Biernasiuk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?